Briacell Therapeutics Corp stock is traded at $3.27, with a volume of 94,849. It is up +2.51% in the last 24 hours and down -18.66% over the past month. BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
Previous Close:
$3.19
Open:
$3.32
24h Volume:
94,849
Relative Volume:
1.39
Market Cap:
$28.55M
Revenue:
-
Net Income/Loss:
-$30.98M
P/E Ratio:
-
EPS:
-$12.21
Net Cash Flow:
-$31.84M
1W Performance:
+7.57%
1M Performance:
-18.66%
6M Performance:
-21.20%
1Y Performance:
-66.73%
1-Day Range:
$0.00$0.00
1-Week Range:
$2.98$3.41
52-Week Range:
$2.60$13.09
Briacell Therapeutics Corp Stock (BCTX) Company Profile
Name
Briacell Therapeutics CorpSector
HealthcareIndustry
BiotechnologyPhone
(604) 921-1810Address
3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER, CanadaMarket Cap
Revenue
Net Income
Cash Flow
EPS